campain cover

Our recommendations

Compliance disclosures

Below you can access a full list of Investment Recommendations, which have been made relating to Lyxor’s range of Exchange Traded Fund. To view current and previous recommendations relating to a specific fund, simply select the ETF name from the drop down menu below.

Latest recommendations

Disclaimer: In accordance with the European Market in Financial Instruments Directive (“MiFID”) and the Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing the Market Abuse Directive and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC as implemented in the Conduct of Business Sourcebook of the Financial Conduct Authority, this document should be treated as a marketing communication providing investment recommendations and should not be treated as a research report issued by Lyxor International Asset Management’s Research department (“Lyxor”). Read More
Lyxor International Asset Management Research Team

In accordance with the European Market in Financial Instruments Directive ("MiFID") and the Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing the Market Abuse Directive and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC as implemented in the Conduct of Business Sourcebook of the Financial Conduct Authority, this document should be treated as a marketing communication providing investment recommendations and should not be treated as a research report issued by Lyxor International Asset Management’s Research department ("Lyxor").

Lyxor has in place policies and procedures to ensure that its employees act in the best interests of clients when providing them with any financial promotions or investment recommendations.

These policies include internal conflicts of interests and personal account dealing policies that are designed to ensure that SG’s employees are not conflicted in the financial promotions that they provide to clients. SG is subject to the provisions of the fourth iteration of the Capital Requirements Directive ("CRD IV"), which requires that institutions’ remuneration policies incorporate measures to avoid conflicts of interest. With this in mind, there is no direct linkage between the investment recommendations given by SG’s employees and any variable remuneration that they receive.

This document may include general investment recommendations issued by Lyxor’s Research department which has set, in accordance with applicable regulation, effective administrative and organizational arrangements, including information Chinese walls, to prevent and avoid conflicts of interest with respect to the investment recommendations contained in this document.

Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. Nothing in this document should be construed as constituting investment advice or personal recommendation (within the meaning of article 4 (4) of the MiFID) to any investor or its agent.

IMPORTANT DISCLAIMER

The information herein is not intended to be an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities and has been obtained from, or is based upon, sources believed to be reliable but is not guaranteed as to accuracy or completeness.

Material contained in this report satisfies the regulatory provisions concerning independent investment research as defined in MiFID.

Information concerning conflicts of interest and Lyxor’s management of such conflicts is contained in the Lyxor’s Policies for Managing Conflicts of Interests in Connection with Investment Research which is available at https://www.lyxor.com

Lyxor does, from time to time, deal, trade in, hold on behalf of, act as investment manager or adviser of collective investment schemes, mandates, portfolio of transferable securities in relation to the securities, or derivatives thereof, of persons, firms or entities mentioned in this document.

Employees of Lyxor, or individuals connected to them, may from time to time have a position in or hold any of the investments or related investments mentioned in this document. Lyxor is under no obligation to disclose or take account of this document when advising or dealing with or on behalf of customers.

trading of, hold, or act as market-makers or as advisers, brokers or bankers in relation to, the products (or derivatives thereof) of entities mentioned in this document or (ii) be represented on the board of such entities. Societe Generale Group employees, or individuals connected to them, may from time to time have a position in or hold any of the products or related investments mentioned in this document.

The views of Lyxor reflected in this document may change without notice. In addition, Lyxor may issue other reports that are inconsistent with, and reach different conclusions from, the information presented in this report and is under no obligation to ensure that such other reports are brought to the attention of any recipient of this report.

To the maximum extent possible at law, Lyxor does not accept any liability whatsoever arising from the use of the material or information contained herein. This research document is not intended for use by or targeted to retail customers.

Should a retail customer obtain a copy of this report he/she should not base his/her investment decisions solely on the basis of this document and must seek independent financial advice.

The financial instruments discussed in this report may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

Changes in currency exchange rates may have an adverse effect on the net asset value ("NAV") or income of the product.

Lyxor does not provide any tax advice. Past performance is not necessarily a guide to future performance. Estimates of future performance are based on assumptions that may not be realized. Investments in general and derivatives in particular, involve numerous risks, including, among others, market, counterparty default and liquidity risk. ETF ownership could result in significant loss or gain. Prior to buying or selling the shares of an ETF, investors shall read carefully the "risk factors" section of the product’s prospectus and Key Investor Information Document (KIID). The prospectus in English and the KIID in the relevant local language (for all the countries referred to, in this document as a country in which a public offer of the product is authorised) are available free of charge on lyxoretf.com or upon request to client-services-etf@ lyxor.com.

Notice to French Investors: This publication is issued in the United Kingdom by or through Lyxor Asset Management UK LLP which is authorised and supervised by the Financial Conduct Authority under Registration Number 435658.

Lyxor International Asset Management is a French management company authorized by the Autorité des marchés financiers and placed under the regulations of the UCITS (2009/65/EC) and AIFM (2011/61/EU) Directives.

Notice to U.K. Investors: Lyxor Asset Management UK LLP is a MIFID investment firm authorised and supervised by the Financial Conduct Authority under Registration Number 435658 and subject to limited regulation by the Financial Conduct Authority. Details about the extent of our authorisation and regulation by the Financial Conduct Authority are available from us on request.

GENERAL DISCLAIMER

This communication is exclusively directed and available to Institutional Investors as defined by the 2004/39/EC Directive on markets in financial instruments acting for their own account and categorized as eligible counterparties or professional clients. This communication is not directed at retail clients.

This document does not constitute an offer, a solicitation or a recommendation to invest in the fund and in particular is not an offer in any jurisdiction where such offer would not be authorized.

The attention of the investor is drawn to the fact that the net asset value stated in this document (as the case may be) cannot be used as a basis for subscriptions and/or redemptions.

This document does not constitute an offer, or an invitation to make an offer, from Lyxor to subscribe for, purchase or sell a product or to execute a product referred to in this document.

The products discussed in this document may not be suitable for all institutional investors and investors must make their own investment decisions (using their own independent investment advisors as they may choose) - based upon specific financial situations and investment objectives.

The products referred to in this document may not be eligible for sale in all jurisdictions and/or may be subject to certain investor qualification requirements in a number of jurisdictions.

Lyxor’s Research department publications supporting this document were issued on their stated publication date and may have already been acted upon by Lyxor’s portfolio managers on behalf of the collective investment schemes, portfolio mandates or clients under investment advisory services.

Lyxor’s salespeople, portfolio managers and other professionals may provide oral or written market commentary or trading strategies to our clients and principal trading desks that reflect opinions that are contrary to the opinions expressed in this research. Lyxor’s asset management team, principal trading desks and investing businesses may make investment decisions that are inconsistent with the recommendations or views expressed in this research.

The accuracy, completeness or relevance of the information which has been drawn from external sources is not guaranteed although it is drawn from sources reasonably believed to be reliable. Subject to any applicable law, Lyxor shall not assume any liability in this respect.

The market information displayed in this document is based on data at a given moment and may change from time to time. In addition, the views reflected herein may change without notice and Lyxor’s sales personnel and traders may issue at any time other material (including on the same product or issuer) that are inconsistent with, and reach different conclusions from, the information presented herein.

No updates to this document are planned. In the event that the reader is unsure as to whether the facts in this document are up-to-date at the time of their proposed investment, then they should seek independent advice. Clients should contact their salespersons to execute transactions with an SG Group entity authorised in their home jurisdiction, unless applicable law permits otherwise. Additional information is available upon request.

This document is confidential and should not be reproduced, published or redistributed without the prior written consent of Lyxor International Asset Management or its affiliates.

NOTICE TO EUROPEAN INVESTORS

THIS DOCUMENT IS FOR THE EXCLUSIVE USE OF INVESTORS ACTING FOR THEIR OWN ACCOUNT AND CATEGORIZED EITHER AS "ELIGIBLE COUNTERPARTIES" OR "PROFESSIONAL CLIENTS" WITHIN THE MEANING OF MARKETS IN FINANCIAL INSTRUMENTS DIRECTIVE 2004/39/CE.